• Holger K Eltzschig and Tobias Eckle.
• Department of Anesthesiology, Mucosal Inflammation Program, University of Colorado, Aurora, Colorado, USA. holger.eltzschig@ucdenver.edu
• Nat. Med. 2011 Nov 7; 17 (11): 1391-401.

AbstractIschemia and reperfusion-elicited tissue injury contributes to morbidity and mortality in a wide range of pathologies, including myocardial infarction, ischemic stroke, acute kidney injury, trauma, circulatory arrest, sickle cell disease and sleep apnea. Ischemia-reperfusion injury is also a major challenge during organ transplantation and cardiothoracic, vascular and general surgery. An imbalance in metabolic supply and demand within the ischemic organ results in profound tissue hypoxia and microvascular dysfunction. Subsequent reperfusion further enhances the activation of innate and adaptive immune responses and cell death programs. Recent advances in understanding the molecular and immunological consequences of ischemia and reperfusion may lead to innovative therapeutic strategies for treating patients with ischemia and reperfusion-associated tissue inflammation and organ dysfunction.

25 keywords...

hide…